-
Mashup Score: 0Retrospective Data Show Metastasectomy Plus Nephrectomy Improves Survival in Non–ccRCC - 2 hour(s) ago
A retrospective analysis showed that metastasectomy plus radical nephrectomy could improve survival in patients with metastatic non–clear cell RCC.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1EV-302 Trial Ushers in Era of Novel Combos in First-Line Metastatic Urothelial Cancer - 3 hour(s) ago
Joaquim Bellmunt, MD, PhD, discusses the impact of enfortumab vedotin plus pembrolizumab on the treatment paradigm in first-line urothelial cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Petros Grivas, MD, PhD, discusses the significance of the phase 3 JAVELIN Bladder 100, EV-302, and CheckMate 901 trials in urothelial cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Dr Rosenberg on Efforts to Enhance Urothelial Cancer Treatment - 7 hour(s) ago
Jonathan E. Rosenberg, MD, discusses ongoing and planned research efforts to enhance the frontline and beyond urothelial cancer treatment landscape.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Merck Discontinues KeyVibe-010 Trial of Vibostolimab/Pembrolizumab in Resected High-Risk Melanoma - 8 hour(s) ago
The phase 3 KeyVibe-010 trial of adjuvant vibostolimab plus pembrolizumab in patients with resected high-risk melanoma has been discontinued.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Robert Wang, MD, discusses the presently limited utility of using molecular imagining with quantitative thresholds in distinguishing RCC from oncocytic renal masses.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Identifying Individual Social Determinants of Health Could Reduce Barriers to Breast Cancer Care - 11 hour(s) ago
Samilia Obeng-Gyasi, MD, MPH, expands on the impact of social determinants of health on breast cancer care.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0OncLive’s April Roundup of Key FDA Decisions in Oncology - 12 hour(s) ago
In case you missed it, below is your guide to the important regulatory approvals made by the FDA in April 2024.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Pirtobrutinib Transforms SOC in Later-Line CLL/SLL - 13 hour(s) ago
Jean L. Koff, MD, MS, highlights data for pirtobrutinib in pretreated CLL/SLL and how the agent altered later-line care for these patients.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Relatlimab Plus Nivolumab/Chemo Misses ORR End Point in LAG-3+ Advanced Gastric/GEJ Cancer - 14 hour(s) ago
Relatlimab plus nivolumab and chemotherapy did not improve responses in untreated advanced gastric or GEJ cancer with a LAG-3 expression of at least 1%.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Findings from a retrospective cohort study showed that patients with metastatic non–ccRCC who underwent metastasectomy and radical nephrectomy experienced improved PFS and OS vs those who received radical nephrectomy alone. @wjurol #kcsm #oncology https://t.co/a2AkNLfnQo